The REporting of A Disproportionality Analysis for DrUg Safety Signal Detection Using Individual Case Safety Reports in PharmacoVigilance (READUS-PV): Explanation and Elaboration

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

Extent: 1 Online-Ressource.

Language: Englisch

Bibliographic citation: The REporting of A Disproportionality Analysis for DrUg Safety Signal Detection Using Individual Case Safety Reports in PharmacoVigilance (READUS-PV): Explanation and Elaboration ; volume:47 ; number:6 ; day:7 ; month:5 ; year:2024 ; pages:585-599 ; date:6.2024
Drug safety ; 47, Heft 6 (7.5.2024), 585-599, 6.2024

Classification: Soziale Probleme, Sozialdienste, Versicherungen

Creator: Fusaroli, Michele
Salvo, Francesco
Begaud, Bernard
AlShammari, Thamir M.
Bate, Andrew
Battini, Vera
Brueckner, Andreas
Candore, Gianmario
Carnovale, Carla
Crisafulli, Salvatore
Cutroneo, Paola Maria
Dolladille, Charles
Drici, Milou-Daniel
Faillie, Jean-Luc
Goldman, Adam
Hauben, Manfred
Herdeiro, Maria Teresa
Mahaux, Olivia
Manlik, Katrin
Montastruc, François
Noguchi, Yoshihiro
Norén, G. Niklas
Noseda, Roberta
Onakpoya, Igho J.
Pariente, Antoine
Poluzzi, Elisabetta
Salem, Myriam
Sartori, Daniele
Trinh, Nhung T. H.
Tuccori, Marco
Hunsel, Florence van
Puijenbroek, Eugène van
Raschi, Emanuel
Khouri, Charles

Contributor: SpringerLink (Online service)

DOI: 10.1007/s40264-024-01423-7

URN: urn:nbn:de:101:1-2408021000253.509017108671

Rights: Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 14.08.2025, 10:50 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Fusaroli, Michele
Salvo, Francesco
Begaud, Bernard
AlShammari, Thamir M.
Bate, Andrew
Battini, Vera
Brueckner, Andreas
Candore, Gianmario
Carnovale, Carla
Crisafulli, Salvatore
Cutroneo, Paola Maria
Dolladille, Charles
Drici, Milou-Daniel
Faillie, Jean-Luc
Goldman, Adam
Hauben, Manfred
Herdeiro, Maria Teresa
Mahaux, Olivia
Manlik, Katrin
Montastruc, François
Noguchi, Yoshihiro
Norén, G. Niklas
Noseda, Roberta
Onakpoya, Igho J.
Pariente, Antoine
Poluzzi, Elisabetta
Salem, Myriam
Sartori, Daniele
Trinh, Nhung T. H.
Tuccori, Marco
Hunsel, Florence van
Puijenbroek, Eugène van
Raschi, Emanuel
Khouri, Charles
SpringerLink (Online service)

Other Objects (12)

Drug safety of rosiglitazone and pioglitazone in France: a study using the French PharmacoVigilance database

The Reporting of a Disproportionality Analysis for Drug Safety Signal Detection Using Individual Case Safety Reports in PharmacoVigilance (READUS-PV): Development and Statement

Big data, medicines safety and pharmacovigilance

Psychiatric adverse events associated with semaglutide, liraglutide and tirzepatide: a pharmacovigilance analysis of individual case safety reports submitted to the EudraVigilance database

Hochschulschrift

Anti-Counterfeiting in Global Pharmacovigilance : A Question of Patient Safety

Improved drug safety through intensive pharmacovigilance in hospitalized pediatric patients

Post-marketing safety concerns with rimegepant based on a pharmacovigilance study

Safety of Nintedanib in Patients with Idiopathic Pulmonary Fibrosis: Global Pharmacovigilance Data

EudraVigilance Medicines Safety Database: Publicly Accessible Data for Research and Public Health Protection

Safety Concerns with HPV Vaccines Continue to Linger: Are Current Vaccine Pharmacovigilance Practices Sufficient?

Safety of factor XIII concentrate : analysis of more than 20 years of pharmacovigilance data

Pharmacovigilance Study of Infigratinib: A Safety Analysis of the FDA Adverse Event Reporting System

Drug safety of rosiglitazone and pioglitazone in France: a study using the French PharmacoVigilance database

The Reporting of a Disproportionality Analysis for Drug Safety Signal Detection Using Individual Case Safety Reports in PharmacoVigilance (READUS-PV): Development and Statement

Big data, medicines safety and pharmacovigilance

Psychiatric adverse events associated with semaglutide, liraglutide and tirzepatide: a pharmacovigilance analysis of individual case safety reports submitted to the EudraVigilance database

Hochschulschrift

Anti-Counterfeiting in Global Pharmacovigilance : A Question of Patient Safety

Improved drug safety through intensive pharmacovigilance in hospitalized pediatric patients

Post-marketing safety concerns with rimegepant based on a pharmacovigilance study

Safety of Nintedanib in Patients with Idiopathic Pulmonary Fibrosis: Global Pharmacovigilance Data

EudraVigilance Medicines Safety Database: Publicly Accessible Data for Research and Public Health Protection

Safety Concerns with HPV Vaccines Continue to Linger: Are Current Vaccine Pharmacovigilance Practices Sufficient?

Safety of factor XIII concentrate : analysis of more than 20 years of pharmacovigilance data

Pharmacovigilance Study of Infigratinib: A Safety Analysis of the FDA Adverse Event Reporting System

Drug safety of rosiglitazone and pioglitazone in France: a study using the French PharmacoVigilance database

The Reporting of a Disproportionality Analysis for Drug Safety Signal Detection Using Individual Case Safety Reports in PharmacoVigilance (READUS-PV): Development and Statement

Big data, medicines safety and pharmacovigilance

Psychiatric adverse events associated with semaglutide, liraglutide and tirzepatide: a pharmacovigilance analysis of individual case safety reports submitted to the EudraVigilance database

Hochschulschrift

Anti-Counterfeiting in Global Pharmacovigilance : A Question of Patient Safety

Improved drug safety through intensive pharmacovigilance in hospitalized pediatric patients

Post-marketing safety concerns with rimegepant based on a pharmacovigilance study

Safety of Nintedanib in Patients with Idiopathic Pulmonary Fibrosis: Global Pharmacovigilance Data

EudraVigilance Medicines Safety Database: Publicly Accessible Data for Research and Public Health Protection

Safety Concerns with HPV Vaccines Continue to Linger: Are Current Vaccine Pharmacovigilance Practices Sufficient?

Safety of factor XIII concentrate : analysis of more than 20 years of pharmacovigilance data

Pharmacovigilance Study of Infigratinib: A Safety Analysis of the FDA Adverse Event Reporting System

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

The REporting of A Disproportionality Analysis for DrUg Safety Signal Detection Using Individual Case Safety Reports in PharmacoVigilance (READUS-PV): Explanation and Elaboration

Object Details

References and Relationships

Classification and Topics

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

Drug safety of rosiglitazone and pioglitazone in France: a study using the French PharmacoVigilance database

The Reporting of a Disproportionality Analysis for Drug Safety Signal Detection Using Individual Case Safety Reports in PharmacoVigilance (READUS-PV): Development and Statement

Big data, medicines safety and pharmacovigilance

Psychiatric adverse events associated with semaglutide, liraglutide and tirzepatide: a pharmacovigilance analysis of individual case safety reports submitted to the EudraVigilance database

Anti-Counterfeiting in Global Pharmacovigilance : A Question of Patient Safety

Improved drug safety through intensive pharmacovigilance in hospitalized pediatric patients

Post-marketing safety concerns with rimegepant based on a pharmacovigilance study

Safety of Nintedanib in Patients with Idiopathic Pulmonary Fibrosis: Global Pharmacovigilance Data

EudraVigilance Medicines Safety Database: Publicly Accessible Data for Research and Public Health Protection

Safety Concerns with HPV Vaccines Continue to Linger: Are Current Vaccine Pharmacovigilance Practices Sufficient?

Safety of factor XIII concentrate : analysis of more than 20 years of pharmacovigilance data

Pharmacovigilance Study of Infigratinib: A Safety Analysis of the FDA Adverse Event Reporting System

Drug safety of rosiglitazone and pioglitazone in France: a study using the French PharmacoVigilance database

The Reporting of a Disproportionality Analysis for Drug Safety Signal Detection Using Individual Case Safety Reports in PharmacoVigilance (READUS-PV): Development and Statement

Big data, medicines safety and pharmacovigilance

Psychiatric adverse events associated with semaglutide, liraglutide and tirzepatide: a pharmacovigilance analysis of individual case safety reports submitted to the EudraVigilance database

Anti-Counterfeiting in Global Pharmacovigilance : A Question of Patient Safety

Improved drug safety through intensive pharmacovigilance in hospitalized pediatric patients

Post-marketing safety concerns with rimegepant based on a pharmacovigilance study

Safety of Nintedanib in Patients with Idiopathic Pulmonary Fibrosis: Global Pharmacovigilance Data

EudraVigilance Medicines Safety Database: Publicly Accessible Data for Research and Public Health Protection

Safety Concerns with HPV Vaccines Continue to Linger: Are Current Vaccine Pharmacovigilance Practices Sufficient?

Safety of factor XIII concentrate : analysis of more than 20 years of pharmacovigilance data

Pharmacovigilance Study of Infigratinib: A Safety Analysis of the FDA Adverse Event Reporting System

Drug safety of rosiglitazone and pioglitazone in France: a study using the French PharmacoVigilance database

The Reporting of a Disproportionality Analysis for Drug Safety Signal Detection Using Individual Case Safety Reports in PharmacoVigilance (READUS-PV): Development and Statement

Big data, medicines safety and pharmacovigilance

Psychiatric adverse events associated with semaglutide, liraglutide and tirzepatide: a pharmacovigilance analysis of individual case safety reports submitted to the EudraVigilance database

Anti-Counterfeiting in Global Pharmacovigilance : A Question of Patient Safety

Improved drug safety through intensive pharmacovigilance in hospitalized pediatric patients

Post-marketing safety concerns with rimegepant based on a pharmacovigilance study

Safety of Nintedanib in Patients with Idiopathic Pulmonary Fibrosis: Global Pharmacovigilance Data

EudraVigilance Medicines Safety Database: Publicly Accessible Data for Research and Public Health Protection

Safety Concerns with HPV Vaccines Continue to Linger: Are Current Vaccine Pharmacovigilance Practices Sufficient?

Safety of factor XIII concentrate : analysis of more than 20 years of pharmacovigilance data

Pharmacovigilance Study of Infigratinib: A Safety Analysis of the FDA Adverse Event Reporting System

Related objects

Reset password